Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard…
sciencecityNovember 8, 2019
Vaccine induction of broadly neutralizing antibodies (bnAbs) to human immunodeficiency virus (HIV) remains a major…
sciencecityNovember 7, 2019
A new study from the laboratory of Frederick Alt, PhD, of the Program in Cellular and Molecular Medicine (PCMM) at…
sciencecityNovember 7, 2019
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling…
sciencecityNovember 7, 2019
A new health care feature from Facebook called “Preventive Health” is aimed at encouraging users…
sciencecityNovember 6, 2019
As people age, they tend to develop diseases such as heart failure, kidney failure, diabetes,…
sciencecityNovember 6, 2019
Researchers from MIT will be collaborating with colleagues at the University of Colorado at Boulder…
sciencecityNovember 6, 2019
Engitix Ltd (‘Engitix’), a private company focused on drug discovery for fibrosis and solid tumours…
sciencecityNovember 6, 2019
Blood clotting in veins, a disorder called venous thromboembolism (VTE), is a common vascular disease…
sciencecityNovember 6, 2019
